Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Depression

New study finds depression decreases cognitive control in both emotional and neutral settings

by Laura Staloch
November 27, 2022
in Depression
Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

A common symptom of depression is difficulty thinking or concentrating. To rephrase, depressed people often lack the cognitive control required to achieve goals. Researchers at the University of Padua, Italy, sought to determine if the lack of cognitive control in depressed people was present when working on tasks that triggered emotions or if it was present even when tasks were emotionally neutral. Additionally, they were interested in what kinds of tasks resulted in less cognitive control.

Their findings indicate that depression results in difficulties in cognitive control in both emotional and neutral tasks. However, when tasks were emotional, subjects experienced a greater struggle with cognitive control than in neutral tasks. In this condition, managing attention became the primary challenge. Finally, repeated tasks were also challenging for subjects.

Prior research has explored several different aspects related to cognitive control and depression. Findings have indicated that those who are depressed struggle to overcome emotional stimuli to solve problems and modulate attention. If the emotional stimuli were unpleasant, the difficulty increased. The current study intends to understand the complexities of cognitive control during depressive episodes.

The research team obtained a sample of 82 volunteer participants. The sample was 63% female, healthy, and not on any psychotropic medications. Participant depression symptoms were measured by the Beck Depression Inventory-II, a proven reliable, and valid measure.

Subjects were then asked to complete a digital activity categorizing a set of blocks. There were simple and more challenging versions of the activity. Sometimes the simple tasks would repeat themselves, and other times there would be switching between simple and complex tasks.

These tasks were divided into “hot” and “cold” conditions. In the “cold” condition, the blocks had geometric shapes that were to be used to facilitate categorizing. The “hot” condition had blocks with images of faces, two of which were smiling and two who looked distressed. Response times for the categorization tasks under all conditions were collected and analyzed.

Carola Dell’Acqua and colleagues expected to find that as depressive symptoms increased, so would response times in the hot condition indicating challenges with cognitive control. They also expected response times to be longer when exposed to distressed faces than happy ones.

The results were surprising as subjects struggled for cognitive control with tasks both “hot” and “cold.” When tasks were repeated in both conditions, there were increased response times compared to single or switching tasks. Additionally, they did not find a difference in response times between tasks with smiling versus distressed faces.

This was also an unexpected finding with Dell’Acqua and team concluding, “our results are in line with one of the few studies that adopted an emotional (with pleasant and unpleasant trials), rather than a non-emotional version of the same task-switching paradigm and found a selective difficulty in the emotional task-switching paradigm, regardless of the stimulus valence, in individuals with depression.”

Some acknowledged limitations of the study include the unsupervised participants and subjects were provided with clear instructions, but there is no way to know if they followed them. Second, the block task used may be limited in what it can reveal about depressive symptoms and cognitive control.

This study serves to help researchers disentangle the complexities of cognitive control, attention, and depression. The research team made this conclusion: “These findings show the presence of depressive symptoms is associated with a general difficulty to exert cognitive control in both contexts and with a more extended difficulty in even simple attentional processing of affective material.”

The study, “Depressive symptoms and cognitive control: the role of affective interference“, was authored by Carola Dell’Acqua, Simone Messerotti Benvenuti, Antonino Vallesi, Daniela Palomba, and Ettore Ambrosini.

TweetSendScanShareSendPin5ShareShareShareShareShare

RELATED

Optimistic individuals are more likely to respond to SSRI antidepressants
Depression

Optimistic individuals are more likely to respond to SSRI antidepressants

May 19, 2025

People with depression who were more optimistic at the start of treatment—and whose optimism increased during treatment—were more likely to benefit from SSRIs, according to a recent study, raising the possibility of tailoring treatments based on psychological traits.

Read moreDetails
Inhaled DMT produces rapid and lasting antidepressant effects in treatment-resistant depression
Ayahuasca

Inhaled DMT produces rapid and lasting antidepressant effects in treatment-resistant depression

May 17, 2025

Vaporized DMT produced fast and lasting improvements in depression symptoms and suicidal ideation, according to a new phase 2a trial, highlighting its potential as a scalable, non-invasive alternative to conventional and long-acting psychedelic treatments for severe depression.

Read moreDetails
New research points to gut serotonin as a potential way to treat depression and anxiety
Depression

New research points to gut serotonin as a potential way to treat depression and anxiety

May 16, 2025

New research reveals that serotonin in the gut lining can reduce anxiety and depression symptoms in mice—without the side effects of traditional antidepressants—and may offer a safer alternative for treating mood disorders during pregnancy.

Read moreDetails
New research links postnatal depression to a disrupted oxytocin response during breastfeeding
Depression

New research links postnatal depression to a disrupted oxytocin response during breastfeeding

May 15, 2025

A new study finds that postnatal depression may impair the body’s hormonal response to breastfeeding. While oxytocin nasal spray boosted breast milk levels in healthy mothers, the same effect was not seen in those experiencing depressive symptoms after childbirth.

Read moreDetails
Stress-induced “fixated” eating patterns linked to dopamine disruption, study finds
Depression

New research links antidepressant effects of escitalopram to endocannabinoid system changes

May 12, 2025

In a rodent model of childhood adversity, escitalopram treatment during adolescence reduced signs of emotional distress. The study also found gene-level changes in the endocannabinoid system, pointing to a possible biological mechanism for the drug’s effectiveness.

Read moreDetails
Antidepressants may diminish psilocybin’s effects even after discontinuation
Depression

A single dose of psilocybin might help reduce symptoms in treatment-resistant depression

May 12, 2025

A new open-label study suggests that a single dose of psilocybin, combined with psychological support, may reduce symptoms in people with severe treatment-resistant depression. Improvements were sustained for up to 12 weeks, although effects were weaker in those with PTSD.

Read moreDetails
A pill bottle with pills inside
Depression

Common antidepressant may increase pain sensitivity later in life if taken during adolescence

May 11, 2025

A new animal study shows that adolescent use of fluoxetine, a commonly prescribed antidepressant, may have long-lasting effects on how the brain processes pain. Female mice exposed to the drug displayed increased sensitivity to heat stimuli as adults.

Read moreDetails
Microdoses of LSD enhance neural complexity, study finds
Depression

Little-known psychedelic drug shows promise in treating low motivation in depression

May 9, 2025

Researchers investigating the psychedelic drug DOPR discovered that very low doses can enhance motivation in low-performing mice—without triggering behaviors linked to hallucinations. The findings point to the therapeutic potential of psychedelics at doses too low to alter perception.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

What brain scans reveal about the neural correlates of pornography consumption

AI chatbots often misrepresent scientific studies — and newer models may be worse

Is gender-affirming care helping or harming mental health?

Study finds “zombie” neurons in the peripheral nervous system contribute to chronic pain

Therapeutic video game shows promise for post-COVID cognitive recovery

Passive scrolling linked to increased anxiety in teens, study finds

Your bodily awareness guides your morality, new neuroscience study suggests

Where you flirt matters: New research shows setting shapes romantic success

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy